Showing results (81-90 of 189) with videos related to
Sort By:
Pageof 19
Human Genetics|May 17, 2001
Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel diseaseA Rector, S Vermeire, I Thoelen, et al.Gut|October 21, 2009
Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapyC Thienpont, A D'Hoore, S Vermeire, et al.Alimentary Pharmacology & Therapeutics|March 19, 2010
Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitisR J Nicholls, D N Clark, L Kelso, et al.Alimentary Pharmacology & Therapeutics|November 11, 2011
Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000N A Kennedy, D N Clark, J Bauer, et al.Acta Gastro-Enterologica Belgica|August 26, 2006
Miliary tuberculosis following infliximab therapy for Crohn disease: A case report and review of the literatureP Stas, A D'Hoore, G Van Assche, et al.Alimentary Pharmacology & Therapeutics|November 22, 2017
Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's diseaseN Vande Casteele, B G Feagan, S Vermeire, et al.Gut|June 15, 2004
Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasisS Vermeire, P Rutgeerts, K Van Steen, et al.Alimentary Pharmacology & Therapeutics|October 6, 2015
Smoking behaviour and knowledge of the health effects of smoking in patients with inflammatory bowel diseaseC De Bie, V Ballet, N Hendriks, et al.Alimentary Pharmacology & Therapeutics|January 11, 2016
Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBDJ Fevery, W Van Steenbergen, J Van Pelt, et al.Pageof 19